Hepatitis B and C in Children

[1]  P. Rosenthal,et al.  Combination of Entecavir/Peginterferon Alfa‐2a in Children With Hepatitis B e Antigen–Positive Immune Tolerant Chronic Hepatitis B Virus Infection , 2019, Hepatology.

[2]  J. Benselin,et al.  Epidemiology and natural history of hepatitis C virus infection among children and young people. , 2019, Journal of hepatology.

[3]  M. Brown,et al.  The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom , 2019, Journal of child health care : for professionals working with children in the hospital and community.

[4]  M. Moafy,et al.  Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4 , 2018, Journal of viral hepatitis.

[5]  Y. Huang,et al.  Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study , 2018, Hepatology.

[6]  S. Rutherford,et al.  Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  N. Hadžić,et al.  Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition , 2017, Journal of pediatric gastroenterology and nutrition.

[8]  S. Hunt,et al.  Health-related Quality of Life in Adolescent Patients With Hepatitis C Genotype 1 Treated With Sofosbuvir and Ledipasvir , 2018, Journal of pediatric gastroenterology and nutrition.

[9]  P. Rosenthal,et al.  Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection , 2017, Hepatology.

[10]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[11]  H. Cheema,et al.  Effectiveness and Safety of Sofosbuvir in Treatment-NäiveChildren with Hepatitis C Infection. , 2017, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[12]  P. Rosenthal,et al.  The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection , 2017, Hepatology.

[13]  P. Rosenthal,et al.  ZIRCON: pharmacokinetics, safety, and efficacy of ombitasvir/ paritaprevir/ritonavir ± dasabuvir ± ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infection , 2017 .

[14]  P. Rosenthal,et al.  Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infection , 2017 .

[15]  A. Petruzziello,et al.  Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes , 2016, World journal of gastroenterology.

[16]  P. Rosenthal,et al.  Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B , 2016, Hepatology.

[17]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[18]  P. Rosenthal,et al.  Children with Chronic Hepatitis B in the United States and Canada. , 2015, The Journal of pediatrics.

[19]  M. Kudo,et al.  Antiviral therapy for chronic hepatitis B: Combination of nucleoside analogs and interferon. , 2015, World journal of hepatology.

[20]  M. Abdel-Hady,et al.  Hepatitis C infection in children , 2015 .

[21]  J. Kao,et al.  Perspectives and control of hepatitis B virus infection in Taiwan. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[22]  E. Cholongitas,et al.  Management of patients with hepatitis B in special populations. , 2015, World journal of gastroenterology.

[23]  P. Li,et al.  Peripheral Blood Mononuclear Cell Traffic Plays a Crucial Role in Mother-to-Infant Transmission of Hepatitis B Virus , 2015, International journal of biological sciences.

[24]  H. Razavi,et al.  Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.

[25]  J. Goss,et al.  Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. , 2014, World journal of gastroenterology.

[26]  P. Tovo,et al.  Natural history of vertically acquired HCV infection and associated autoimmune phenomena , 2014, European Journal of Pediatrics.

[27]  G. Mieli-Vergani,et al.  Treatment of chronic viral hepatitis C in children and adolescents: UK experience , 2014, Archives of Disease in Childhood.

[28]  N. Kamal,et al.  Burden of pediatric hepatitis C. , 2013, World journal of gastroenterology.

[29]  G. Mieli-Vergani,et al.  Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. , 2013, Journal of hepatology.

[30]  V. Ng,et al.  Chronic hepatitis B virus (HBV) infection in children: 25 years' experience , 2013, Journal of viral hepatitis.

[31]  D. Kelly,et al.  Chronic Hepatitis B in Children and Adolescents: Epidemiology and Management , 2013, Pediatric Drugs.

[32]  P. Pang,et al.  Randomized, placebo‐controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B , 2012, Hepatology.

[33]  P. Rosenthal,et al.  Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS‐C) trial , 2012, Hepatology.

[34]  P. Rosenthal,et al.  NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. , 2012, Journal of pediatric gastroenterology and nutrition.

[35]  M. Brundler,et al.  Chronic hepatitis C in children – review of natural history at a National Centre , 2011, Journal of viral hepatitis.

[36]  Joan M. Block,et al.  Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options , 2010, Hepatology.

[37]  K. Butler,et al.  Hepatitis B virus infection in children. , 2009, Irish medical journal.

[38]  S. Locarnini,et al.  Perinatal transmission of hepatitis B virus: an Australian experience , 2009, The Medical journal of Australia.

[39]  P. Rosenthal,et al.  Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes , 2009, Journal of pediatric gastroenterology and nutrition.

[40]  M. Jonas,et al.  Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B , 2008, Hepatology.

[41]  T. To,et al.  Spontaneous clearance of childhood hepatitis C virus infection , 2007, Journal of viral hepatitis.

[42]  J. Koskinas,et al.  Natural History of Chronic Hepatitis B Virus Infection in Children of Different Ethnic Origins: A Cohort Study with Up to 12 Years' Follow-up in Northern Greece , 2007, Journal of pediatric gastroenterology and nutrition.

[43]  N. Barshes,et al.  The natural history of hepatitis C virus in pediatric liver transplant recipients , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[44]  M. Jonas,et al.  Long‐term lamivudine therapy for children with HBeAg‐positive chronic hepatitis B , 2006, Hepatology.

[45]  M. Alter,et al.  Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. , 2005, The Journal of infectious diseases.

[46]  R. Standish,et al.  Natural history of hepatitis B in perinatally infected carriers , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[47]  H. Hsu,et al.  The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. , 2004, The Journal of pediatrics.

[48]  G. Zuin,et al.  Clinical features and progression of perinatally acquired hepatitis C virus infection , 2003, Journal of medical virology.

[49]  M. Kundi,et al.  Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. , 2003, The Journal of infectious diseases.

[50]  H. Yu,et al.  Hepatitis B virus S gene mutants in infants infected despite immunoprophylaxis. , 2001, Chinese medical journal.

[51]  W. London,et al.  Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. , 1997, The Journal of infectious diseases.

[52]  W P Havens,et al.  Viral hepatitis. , 1970, The Medical clinics of North America.